Lenalidomide Maintenance Therapy for Multiple Myeloma
Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM)
A Phase II Trial of Anti-KIR in Smoldering Multiple Myeloma
Optimising Renal Outcome in Myeloma Renal Failure
† Study has passed its completion date and status has not been verified in more than two years.